152 related articles for article (PubMed ID: 31754972)
1. The effect of myeloperoxidase isoforms on biophysical properties of red blood cells.
Shamova EV; Gorudko IV; Grigorieva DV; Sokolov AV; Kokhan AU; Melnikova GB; Yafremau NA; Gusev SA; Sveshnikova AN; Vasilyev VB; Cherenkevich SN; Panasenko OM
Mol Cell Biochem; 2020 Jan; 464(1-2):119-130. PubMed ID: 31754972
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil activation in response to monomeric myeloperoxidase.
Gorudko IV; Grigorieva DV; Sokolov AV; Shamova EV; Kostevich VA; Kudryavtsev IV; Syromiatnikova ED; Vasilyev VB; Cherenkevich SN; Panasenko OM
Biochem Cell Biol; 2018 Oct; 96(5):592-601. PubMed ID: 29585927
[TBL] [Abstract][Full Text] [Related]
3. Binding of human myeloperoxidase to red blood cells: Molecular targets and biophysical consequences at the plasma membrane level.
Gorudko IV; Sokolov AV; Shamova EV; Grigorieva DV; Mironova EV; Kudryavtsev IV; Gusev SA; Gusev AA; Chekanov AV; Vasilyev VB; Cherenkevich SN; Panasenko OM; Timoshenko AV
Arch Biochem Biophys; 2016 Feb; 591():87-97. PubMed ID: 26714302
[TBL] [Abstract][Full Text] [Related]
4. [Enzymatic and bactericidal activity of monomeric and dimeric forms of myeloperoxidase].
Vakhrusheva TV; Sokolov AV; Kostevich VA; Vasilyev VB; Panasenko OM
Biomed Khim; 2018 Mar; 64(2):175-182. PubMed ID: 29723147
[TBL] [Abstract][Full Text] [Related]
5. Structure-biological activity relationships of myeloperoxidase to effect on platelet activation.
Gorudko IV; Grigorieva DV; Shamova EV; Gorbunov NP; Kokhan AU; Kostevich VA; Vasilyev VB; Panasenko OM; Khinevich NV; Bandarenka HV; Burko AA; Sokolov AV
Arch Biochem Biophys; 2022 Oct; 728():109353. PubMed ID: 35853481
[TBL] [Abstract][Full Text] [Related]
6. Distinct chromatographic forms of human hemi-myeloperoxidase obtained by reductive cleavage of the dimeric enzyme. Evidence for subunit heterogeneity.
Taylor KL; Guzman GS; Pohl J; Kinkade JM
J Biol Chem; 1990 Sep; 265(26):15938-46. PubMed ID: 2168427
[TBL] [Abstract][Full Text] [Related]
7. Human hemi-myeloperoxidase. Initial chlorinating activity at neutral pH, compound II and III formation, and stability towards hypochlorous acid and high temperature.
Zuurbier KW; van den Berg JD; Van Gelder BF; Muijsers AO
Eur J Biochem; 1992 Apr; 205(2):737-42. PubMed ID: 1315274
[TBL] [Abstract][Full Text] [Related]
8. Red blood cells serve as intravascular carriers of myeloperoxidase.
Adam M; Gajdova S; Kolarova H; Kubala L; Lau D; Geisler A; Ravekes T; Rudolph V; Tsao PS; Blankenberg S; Baldus S; Klinke A
J Mol Cell Cardiol; 2014 Sep; 74():353-63. PubMed ID: 24976018
[TBL] [Abstract][Full Text] [Related]
9. Conformational and thermal stability of mature dimeric human myeloperoxidase and a recombinant monomeric form from CHO cells.
Banerjee S; Stampler J; Furtmüller PG; Obinger C
Biochim Biophys Acta; 2011 Feb; 1814(2):375-87. PubMed ID: 20933108
[TBL] [Abstract][Full Text] [Related]
10. Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer.
Saed GM; Nawaz A; Alvero AA; Harper AK; Morris RT
Biomarkers; 2023 Dec; 28(7):663-671. PubMed ID: 37982229
[No Abstract] [Full Text] [Related]
11. Myeloperoxidase Is a Negative Regulator of Phospholipid-Dependent Coagulation.
Beckmann L; Dicke C; Spath B; Lehr C; Sievers B; Klinke A; Baldus S; Rudolph V; Langer F
Thromb Haemost; 2017 Dec; 117(12):2300-2311. PubMed ID: 29212118
[TBL] [Abstract][Full Text] [Related]
12. Characterizing pathology in erythrocytes using morphological and biophysical membrane properties: Relation to impaired hemorheology and cardiovascular function in rheumatoid arthritis.
Olumuyiwa-Akeredolu OO; Soma P; Buys AV; Debusho LK; Pretorius E
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2381-2391. PubMed ID: 28919343
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
[TBL] [Abstract][Full Text] [Related]
14. Prolonged storage of red blood cells affects aminophospholipid translocase activity.
Verhoeven AJ; Hilarius PM; Dekkers DW; Lagerberg JW; de Korte D
Vox Sang; 2006 Oct; 91(3):244-51. PubMed ID: 16958837
[TBL] [Abstract][Full Text] [Related]
15. Targeting myeloperoxidase to azurophilic granules in HL-60 cells.
Lemansky P; Gerecitano-Schmidek M; Das RC; Schmidt B; Hasilik A
J Leukoc Biol; 2003 Oct; 74(4):542-50. PubMed ID: 12960244
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: glycosylation is required for optimal enzymatic activity.
Van Antwerpen P; Slomianny MC; Boudjeltia KZ; Delporte C; Faid V; Calay D; Rousseau A; Moguilevsky N; Raes M; Vanhamme L; Furtmüller PG; Obinger C; Vanhaeverbeek M; Nève J; Michalski JC
J Biol Chem; 2010 May; 285(21):16351-9. PubMed ID: 20332087
[TBL] [Abstract][Full Text] [Related]
17. Stored red blood cell susceptibility to in vitro transfusion-associated stress conditions is higher after longer storage and increased by storage in saline-adenine-glucose-mannitol compared to AS-1.
Mittag D; Sran A; Chan KS; Boland MP; Bandala-Sanchez E; Huet O; Xu W; Sparrow RL
Transfusion; 2015 Sep; 55(9):2197-206. PubMed ID: 25968419
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase Stimulates Neutrophil Degranulation.
Grigorieva DV; Gorudko IV; Sokolov AV; Kostevich VA; Vasilyev VB; Cherenkevich SN; Panasenko OM
Bull Exp Biol Med; 2016 Aug; 161(4):495-500. PubMed ID: 27597056
[TBL] [Abstract][Full Text] [Related]
19. The reductive cleavage of myeloperoxidase in half, producing enzymically active hemi-myeloperoxidase.
Andrews PC; Krinsky NI
J Biol Chem; 1981 May; 256(9):4211-8. PubMed ID: 6260790
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte phosphatidylserine exposure in β-thalassemia.
Ibrahim HA; Fouda MI; Yahya RS; Abousamra NK; Abd Elazim RA
Lab Hematol; 2014 Jun; 20(2):9-14. PubMed ID: 25000947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
